生物
抗生素耐药性
人口
抗菌剂
微生物学
病毒学
中国
抗性(生态学)
抗药性
抗感染药
肺炎克雷伯菌
遗传学
细菌
流行病学监测
后天抵抗
作者
Jie Che,Hanying Dai,Jie Li,Bohan Chen,Chunying Zhang,Luyao Guo,Dongshan Yan,Hairui Wang,Xueping Liu,Li Xu,Yuan Gao,Yunchuan Qiao,Maojun Zhang,Zhujun Shao
标识
DOI:10.1016/j.jinf.2026.106900
摘要
BACKGROUND: Widespread pneumococcal conjugate vaccine (PCV) usage has reshaped the Streptococcus pneumoniae population and antimicrobial resistance (AMR) globally. However, under the unique ecological setting of critically low PCV coverage and intensive antimicrobial consumption in China, the genomic epidemiological characteristics of prevalent pneumococcal strains remain largely unclear. METHODS: To characterize circulating S. pneumoniae lineages in China, 2841 isolates collected across 29 provinces between 2008 and 2025 were compared against global genomes. Pipelines were used for serotyping, Global Pneumococcal Sequence Cluster (GPSC) assignment, and PCV coverage estimation. AMR was predicted via resistance gene identification and random forest modeling, while phylogenetic and recombination analyses elucidated the evolutionary dynamics of GPSC12 and GPSC3 lineages. FINDINGS: From 2008 to 2025, the Chinese S. pneumoniae population has been dominated by the multidrug-resistant GPSC1, which drives penicillin non-susceptibility despite its recent temporal decline. This population imposes a severe AMR burden, with 98.87% of isolates resistant to at least one class; specifically, resistance rates were 97.18% for macrolide-lincosamide-streptogramin B (MLSb), 97.15% for tetracycline, and 79.23% for trimethoprim-sulfamethoxazole. Estimated coverage for PCV13, PCV15, and PCV20 was 72.69%, 73.39%, and 78.35%, respectively. Notably, the expansion of the serotype 3 lineages GPSC12 and GPSC3 signals a shift in population dynamics: GPSC12 maintains its serotype 3 phenotype via a highly conserved cps locus, whereas GPSC3 acquired this phenotype through an ancestral capsular switch and rapid clonal dissemination. CONCLUSIONS: Our findings demonstrate that China exhibits a distinctly different pneumococcal genomic landscape compared to countries with routine PCV programs. This unique structure is defined by an extreme, GPSC1-driven multidrug resistance burden and active temporal shifts, including the progressive expansion of divergent serotype 3 lineages. Despite these epidemiological and antimicrobial resistance challenges, existing PCVs retain substantial potential serotype coverage against the circulating pneumococcal population in China. These findings highlight the urgent need for sustained longitudinal genomic surveillance and underscore the substantial potential of PCV in optimizing precision disease control.
科研通智能强力驱动
Strongly Powered by AbleSci AI